JOEY SANTOS: Open Payments
NPI 1386656114 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,494 in 67 payments from 15 companies in 2025. Trend: 2023 $3,139 · 2024 $3,595 · 2025 $2,494
Food & beverage: $2,494
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $777 |
| UCB, Inc. | 8 | $276 |
| Vanda Pharmaceuticals Inc. | 2 | $245 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $229 |
| Kowa Pharmaceuticals America, Inc. | 5 | $190 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $189 |
| GlaxoSmithKline, LLC. | 4 | $154 |
| Novo Nordisk Inc | 1 | $120 |
| ACADIA Pharmaceuticals Inc | 4 | $88 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
Products named: AIRSUPRA, BREZTRI, FANAPT, Nayzilam, CAPLYTA, ZORYVE, Kerendia, REXULTI.
Industry payments across CA — which companies pay providers there.
